Loading company…
Moscow-based yRisk sells a genetic test that screens 42 genes for mutations linked to hereditary cancer predisposition.
Based in Moscow, Russia, yRisk provides a genetic testing tool that reveals predisposition to hereditary forms of cancer by checking 42 genes for mutations. The test comes with an electronic detailed report, a scientific directory that explains results, personal recommendations and independent verification. The company is at Seed stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in